Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Guided Therapeutics (GTHP) Work In Process (2016 - 2021)

Guided Therapeutics' Work In Process history spans 8 years, with the latest figure at $80000.0 for Q1 2021.

  • For Q1 2021, Work In Process fell 1.23% year-over-year to $80000.0; the TTM value through Mar 2021 reached $80000.0, down 1.23%, while the annual FY2020 figure was $80000.0, 1.23% down from the prior year.
  • Work In Process for Q1 2021 was $80000.0 at Guided Therapeutics, roughly flat from $80000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $115000.0 in Q1 2017 and bottomed at $80000.0 in Q3 2020.
  • The 5-year median for Work In Process is $81000.0 (2018), against an average of $85000.0.
  • The largest annual shift saw Work In Process crashed 69.37% in 2017 before it changed 0.0% in 2019.
  • A 5-year view of Work In Process shows it stood at $82000.0 in 2017, then dropped by 1.22% to $81000.0 in 2018, then changed by 0.0% to $81000.0 in 2019, then decreased by 1.23% to $80000.0 in 2020, then changed by 0.0% to $80000.0 in 2021.
  • Per Business Quant, the three most recent readings for GTHP's Work In Process are $80000.0 (Q1 2021), $80000.0 (Q4 2020), and $80000.0 (Q3 2020).